The EPS projection of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) for quarter ended 2016-09-30 is $0.28. A week before, the EPS forecast was $0.28 against target of $0.28, a month earlier. This estimate stood at $0.28 60 days earlier versus forecast of $0.28 90 days earlier, confirming a deviation of 0%.
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) reported that 18 days ago, the positive EPS revisions were 0 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 0, 0 and 0, respectively.
The downgrade of EPS estimates for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) in the preceding 120, 60, 30 and 90 days were 0, 1, 0 and 1, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) was $0.28. This projection was computed after accounting 3 calls. As reported on 2016-05-04 the EPS was $0.21. The change was $0.01, demonstrating a percentage deviation of 5%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) stands at $59.277 and the median estimate at $59.885. Almost 4 analysts announced their estimates.
The highest estimate is $60.73 while the lowest target is $56.609 showing standard deviation of 1.825%.
As many as 4 analysts released sales estimates reised in upside while 4 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 4 revised sales number projection on upside while 4 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 4 hiked sales estimations and 4 reduced sales forecast. Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) stated that the change in forecast was 1.604%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...